Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, she pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys teaching and working with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Screening
Cancer risk and use of common medications
Chubak J, Dalmat RR, Weiss NS, Doria-Rose VP, Corley DA, Kamineni A Informative presence in electronic health record data: a challenge in implementing study exclusion criteria 2023 Jan;34(1):29-32. doi: 10.1097/EDE.0000000000001542. Epub 2022-09-16. PubMed
Sarma EA, Thompson MJ, Bowles EJA, Burnett-Hartman AN, Hubbard RA, Yu O, Chubak J Patient and Tumour Characteristics of Screening-Age Adults Diagnosed with Screen-Detected versus Symptomatic Colon Cancer 2022 Nov;24(11):1344-1351. doi: 10.1111/codi.16232. Epub 2022-06-23. PubMed
Feldman S, Lykken JM, Haas JS, Werner CL, Kobrin SC, Tiro JA, Chubak J, Kamineni A Factors associated with timely colposcopy following an abnormal cervical cancer test result 2022 Nov;164:107307. doi: 10.1016/j.ypmed.2022.107307. Epub 2022-10-18. PubMed
Kamineni A, Doria-Rose VP, Chubak J, Inadomi JM, Corley DA, Haas JS, Kobrin SC, Winer RL, Elston Lafata J, Beaber EF, Yudkin JS, Zheng Y, Skinner CS, Schottinger JE, Ritzwoller DP, Croswell JM, Burnett-Hartman AN Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines 2022 Nov;175(11):1582-1590. doi: 10.7326/M22-1139. Epub 2022-09-27. PubMed
Nicholson BD, Thompson MJ, Hobbs FDR, Nguyen M, McLellan J, Green B, Chubak J, Oke JL Measured weight loss as a precursor to cancer diagnosis: retrospective cohort analysis of 43 302 primary care patients 2022 Oct;13(5):2492-2503. doi: 10.1002/jcsm.13051. Epub 2022-07-28. PubMed
Pocobelli G, Ichikawa L, Yu O, Green BB, Meyers K, Gray R, Shea M, Chubak J Validation of international classification of diseases, tenth revision, clinical modification diagnosis codes for heart failure subtypes 2022 Sep;31(9):992-997. doi: 10.1002/pds.5489. Epub 2022-06-07. PubMed
Beaber EF, Kamineni A, Burnett-Hartman AN, Hixon B, Kobrin SC, Li CI, Oliver M, Rendle KA, Skinner CS, Todd K, Zheng Y, Ziebell RA, Breslau ES, Chubak J, Corley DA, Greenlee RT, Haas JS, Halm EA, Honda S, Neslund-Dudas C, Ritzwoller DP, Schottinger JE, Tiro JA, Vachani A, Doria-Rose VP Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda 2022 Aug 2;31(8):1521-1531. doi: 10.1158/1055-9965.EPI-22-0100. PubMed
The findings can help guide colorectal cancer screening decisions later in life.
Understanding emergency department use among adolescent and young adult cancer survivors can help address care gaps.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.